CC logo

The Chemours Company Stock Price

NYSE:CC Community·US$2.7b Market Cap
  • 4 Narratives written by author
  • 8 Comments on narratives written by author
  • 37 Fair Values set on narratives written by author

CC Share Price Performance

US$18.85
5.22 (38.30%)
US$26.33
Fair Value
US$18.85
5.22 (38.30%)
28.4% undervalued intrinsic discount
US$26.33
Fair Value
Price US$18.85
AnalystConsensusTarget US$26.33
AnalystLowTarget US$21.00
AnalystHighTarget US$30.00

CC Community Narratives

·
Fair Value US$26.33 28.4% undervalued intrinsic discount

CC: Global Supply Agreements And Buybacks Will Drive Undervalued Shares Higher

0users have liked this narrative
0users have commented on this narrative
11users have followed this narrative
·
Fair Value US$21 10.2% undervalued intrinsic discount

Escalating PFAS Liabilities And Cost Pressures Will Weigh Future Prospects

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
·
Fair Value US$30 37.2% undervalued intrinsic discount

Opteon Refrigerants And Clean Energy Will Revolutionize Material Markets

0users have liked this narrative
0users have commented on this narrative
3users have followed this narrative
US$30
37.2% undervalued intrinsic discount
Profit Margin
19.53%
Future PE
4.25x
Price in 2029
US$39.3

Trending Discussion

Updated Narratives

CC logo

CC: PFAS Settlement And Updated Outlook Will Shape Balanced Future Expectations

Fair Value: US$21 10.2% undervalued intrinsic discount
0 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
CC logo

CC: Raised Margins And 2026 Outlook Will Support Further Earnings Upside

Fair Value: US$30 37.2% undervalued intrinsic discount
3 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
CC logo

CC: Regulatory Reset And Margin Rebound Will Drive Re Rating Potential

Fair Value: US$26.33 28.4% undervalued intrinsic discount
11 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Very undervalued with reasonable growth potential.

2 Risks
4 Rewards

The Chemours Company Key Details

US$5.8b

Revenue

US$4.9b

Cost of Revenue

US$885.0m

Gross Profit

US$1.3b

Other Expenses

-US$410.0m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
-2.73
15.20%
-7.04%
1,900.0%
View Full Analysis

About CC

Founded
2014
Employees
5700
CEO
Denise M. Dignam
WebsiteView website
www.chemours.com

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. The company operates through three segments: Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials. The Thermal & Specialized Solutions segment provides refrigerants, thermal management solutions, propellants, foam blowing agents, and specialty solvents under the Freon and Opteon brand names. The Titanium Technologies segment offers TiO2 pigment, a white pigment that delivers whiteness, brightness, opacity, durability, efficiency, and protection in applications, including architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard for use in packaging under the Ti-Pure brand name. The Advanced Performance Materials segment products portfolio includes various specialty product solutions, membranes, industrial resins, additives, films, and coatings for consumer electronics, semiconductors, digital communications, transportation, energy, oil and gas, and medical markets under the Teflon, Viton, Krytox, and Nafion brand names. It sells its products through direct and indirect channels, as well as through a network of resellers, third-party sales agents, and distributors. The Chemours Company was incorporated in 2014 and is headquartered in Wilmington, Delaware.

Recent CC News & Updates

Narrative Update Jul 06

CC: PFAS Settlement And Updated Outlook Will Shape Balanced Future Expectations

Analysts have raised their Chemours fair value estimate from $17.00 to $21.00, citing updated views on discount rate assumptions, revenue growth, profit margins and potential future P/E levels. What’s in the News for Chemours Chemours agreed to a multi-site PFAS settlement with the U.S. Environmental Protection Agency, the Department of Justice, the West Virginia Department of Environmental Protection, and multiple states, with total costs reported at more than US$450 million for penalties, mitigation projects, pollution controls, and community water initiatives.
Narrative Update Jun 22

CC: Raised Margins And 2026 Outlook Will Support Further Earnings Upside

Analysts maintained their $30.00 price target on Chemours, citing updated assumptions for the discount rate, revenue growth, profit margin, and future P/E that together support keeping the prior valuation level. What’s in the News for Chemours Chemours issued earnings guidance for the second quarter of 2026, indicating an expected sequential change in consolidated net sales in a range of 15% to 20%, which the company links to seasonal trends.

Recent updates

No updates